Literature DB >> 22476982

Protective effects of curcumin on amyloid-β-induced neuronal oxidative damage.

Han-Chang Huang1, Ping Chang, Xue-Ling Dai, Zhao-Feng Jiang.   

Abstract

To investigate the protective effects of curcumin against amyloid-β (Aβ)-induced neuronal damage. Primary rat cortical neurons were cultured with different treatments of Aβ and curcumin. Neuronal morphologies, viability and damage were assessed. Neuronal oxidative stress was assessed, including extracellular hydrogen peroxide and intracellular reactive oxygen species. The abilities of curcumin to scavenge free radicals and to inhibit Aβ aggregation and β-sheeted formation are further assessed and discussed. Curcumin preserves cell viability, which is decreased by Aβ. The results of changed morphology, released Lactate dehydrogenases and cell viability assays indicate that curcumin protects Aβ-induced neuronal damage. Curcumin depresses Aβ-induced up-regulation of neuronal oxidative stress. The treatment sequence impacts the protective effect of curcumin on Aβ-induced neuronal damage. Curcumin shows a more protective effect on neuronal oxidative damage when curcumin was added into cultured neurons not later than Aβ, especially prior to Aβ. The abilities of curcumin to scavenge free radicals and to inhibit the formation of β-sheeted aggregation are both beneficial to depress Aβ-induced oxidative damage. Curcumin prevents neurons from Aβ-induced oxidative damage, implying the therapeutic usage for the treatment of Alzheimer's disease patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22476982     DOI: 10.1007/s11064-012-0754-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  49 in total

1.  Amyloid beta oligomers induce impairment of neuronal insulin receptors.

Authors:  Wei-Qin Zhao; Fernanda G De Felice; Sara Fernandez; Hui Chen; Mary P Lambert; Michael J Quon; Grant A Krafft; William L Klein
Journal:  FASEB J       Date:  2007-08-24       Impact factor: 5.191

Review 2.  Redox regulation of cellular stress response in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Eleonora Guagliano; Maria Sapienza; Cesare Mancuso; D Allan Butterfield; Anna Maria Giuffrida Stella
Journal:  Ital J Biochem       Date:  2006 Sep-Dec

Review 3.  Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.

Authors:  Vello Tõugu; Ann Tiiman; Peep Palumaa
Journal:  Metallomics       Date:  2011-02-25       Impact factor: 4.526

4.  Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein.

Authors:  Can Zhang; Andrew Browne; Daniel Child; Rudolph E Tanzi
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

Review 5.  The promise of slow down ageing may come from curcumin.

Authors:  E Sikora; A Bielak-Zmijewska; G Mosieniak; K Piwocka
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

6.  Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.

Authors:  Lisa Mosconi; Lidia Glodzik; Rachel Mistur; Pauline McHugh; Kenneth E Rich; Elizabeth Javier; Schantel Williams; Elizabeth Pirraglia; Susan De Santi; Pankaj D Mehta; Raymond Zinkowski; Kaj Blennow; Domenico Pratico; Mony J de Leon
Journal:  Biol Psychiatry       Date:  2010-11-15       Impact factor: 13.382

Review 7.  Metals, toxicity and oxidative stress.

Authors:  M Valko; H Morris; M T D Cronin
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

8.  Antioxidative effects of curcumin and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles.

Authors:  Fang Dai; Wei-Feng Chen; Bo Zhou; Li Yang; Zhong-Li Liu
Journal:  Phytother Res       Date:  2009-09       Impact factor: 5.878

9.  Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation.

Authors:  So-Young Park; Hyo-Shin Kim; Eun-Kyung Cho; Bo-Youn Kwon; Sohee Phark; Kwang-Woo Hwang; Donggeun Sul
Journal:  Food Chem Toxicol       Date:  2008-06-04       Impact factor: 6.023

10.  Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation.

Authors:  Yumei Fu; Shizhong Zheng; Jianguo Lin; Jan Ryerse; Anping Chen
Journal:  Mol Pharmacol       Date:  2007-11-15       Impact factor: 4.436

View more
  9 in total

1.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

2.  The Neuroprotective Effect of Curcumin Against Nicotine-Induced Neurotoxicity is Mediated by CREB-BDNF Signaling Pathway.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Sulail Fatima; Fahimeh Faraji; Shiva Mozaffari
Journal:  Neurochem Res       Date:  2017-06-12       Impact factor: 3.996

Review 3.  Trials with 'epigenetic' drugs: an update.

Authors:  Angela Nebbioso; Vincenzo Carafa; Rosaria Benedetti; Lucia Altucci
Journal:  Mol Oncol       Date:  2012-10-06       Impact factor: 6.603

Review 4.  Biopharmaceutical Monotargeting versus 'Universal Targeting' of Late-Onset Alzheimer's Disease Using Mixtures of Pleiotropic Natural Compounds.

Authors:  Howard Friel
Journal:  J Alzheimers Dis Rep       Date:  2019-07-24

Review 5.  Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.

Authors:  Bruno Fonseca-Santos; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2015-08-04

Review 6.  Curcumin: a natural substance with potential efficacy in Alzheimer's disease.

Authors:  Pamela E Potter
Journal:  J Exp Pharmacol       Date:  2013-05-02

7.  Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease.

Authors:  Shengnuo Fan; Yuqiu Zheng; Xuan Liu; Wenli Fang; Xiaoyu Chen; Wang Liao; Xiuna Jing; Ming Lei; Enxiang Tao; Qiulan Ma; Xingmei Zhang; Rui Guo; Jun Liu
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

8.  Inhibiting amyloid-β cytotoxicity through its interaction with the cell surface receptor LilrB2 by structure-based design.

Authors:  Qin Cao; Woo Shik Shin; Henry Chan; Celine K Vuong; Bethany Dubois; Binsen Li; Kevin A Murray; Michael R Sawaya; Juli Feigon; Douglas L Black; David S Eisenberg; Lin Jiang
Journal:  Nat Chem       Date:  2018-10-08       Impact factor: 24.427

9.  β-Asarone Ameliorates β-Amyloid-Induced Neurotoxicity in PC12 Cells by Activating P13K/Akt/Nrf2 Signaling Pathway.

Authors:  Miaomiao Meng; Lijuan Zhang; Di Ai; Hongyun Wu; Wei Peng
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.